{
    "2019-07-08": [
        [
            {
                "time": "2019-07-08",
                "original_text": "Health Care Sector Update for 07/08/2019: SGMO, PFE, ITCI, PRVL, JNJ, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "Update",
                        "SGMO",
                        "PFE",
                        "ITCI",
                        "PRVL",
                        "JNJ",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-08",
                "original_text": "Johnson & Johnson: How Does Darzalex Compare To Other Multiple Myeloma Drugs?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Darzalex",
                        "Multiple Myeloma",
                        "Drugs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}